Literature DB >> 11321580

In search of natural substrates and inhibitors of MDR pumps.

K Lewis1.   

Abstract

The function of microbial MDRs remains a hotly debated subject. Given the very broad substrate specificities of some MDRs, like the RND pumps that can extrude all classes of amphipathic compounds (cationic, neutral, and anionic), it seems difficult to develop a rationale for pinpointing possible natural substrates of these translocases. At the same time, several clues can be used to guide our search for natural MDR substrates. One is the fact that amphipathic cations appear to be the preferred substrates of MDRs. These substances are extruded by MDRs of all 5 known families and are the almost exclusive substrates of SMR and MF family MDRs. The universal nature of amphipathic cations as MDR substrates suggests that these were the substances that fueled the evolution of MDR pumps. Two factors apparently favored this particular class of molecules for the role of original MDR substrates--need and opportunity. Unlike other substances, amphipathic cations accumulate in the cell driven by the membrane potential, which makes cations potentially the most dangerous toxins. At the same time, amphipathic cations are highly hydrated and do not permeate the membrane as readily as neutral compounds, making it feasible to design a defense based on an efflux pump. The paucity of known cationic (non-basic) antimicrobials might be a result of using MDR-expressing microbial cells for antibiotic discovery. Plant amphipathic cations, the berberine alkaloids, are good MDR substrates. The Berberis plants produce 5'-methoxyhydnocarpin-D, an MDR inhibitor that potentiates the action of berberine. It is suggested that the further evolution of MDR pumps was determined largely by the barrier function of the membrane they reside in. Thus Gram negative bacteria have an outer membrane barrier that slows the penetration of virtually all amphipathic molecules, and transenvelope MDRs of the RND and EmrAB-type extrude their substrates across this barrier. A low permeability of the cytoplasmic membrane of yeast similarly allows for the operation of broad-specificity ABC and MF MDRs. The presence of MDR sensors that regulate the expression of some MDR pumps strongly suggests that defense against external toxins is the function of these MDRs. The BmrR transcriptional activator of the MerR family induces expression of the Bmr pump in B. subtilis and is a sensor specifically designed to recognize amphipathic cations. Similarly, the OacR repressor binds chemically unrelated cations, which leads to the expression of the QacA pump in S. aureus. In E. coli, the EmrR sensor of the MarR repressor family binds unrelated neutral molecules, allowing for expression of the transenvelope EmrAB pump.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11321580

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  29 in total

1.  Move it on out with MATEs.

Authors:  N A Eckardt
Journal:  Plant Cell       Date:  2001-07       Impact factor: 11.277

2.  Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

Authors:  George Tegos; Frank R Stermitz; Olga Lomovskaya; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

3.  ELM1 is required for multidrug resistance in Saccharomyces cerevisiae.

Authors:  Abdul-Kader Souid; Chen Gao; Luming Wang; Elena Milgrom; W-C Winston Shen
Journal:  Genetics       Date:  2006-06-04       Impact factor: 4.562

Review 4.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.

Authors:  Céline Vidaillac; Jean Guillon; Corinne Arpin; Isabelle Forfar-Bares; Boubakar B Ba; Jean Grellet; Stéphane Moreau; Daniel-Henri Caignard; Christian Jarry; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

6.  Reducing the Bottleneck in Discovery of Novel Antibiotics.

Authors:  Marcus B Jones; William C Nierman; Yue Shan; Bryan C Frank; Amy Spoering; Losee Ling; Aaron Peoples; Ashley Zullo; Kim Lewis; Karen E Nelson
Journal:  Microb Ecol       Date:  2016-11-28       Impact factor: 4.552

7.  Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A.

Authors:  Peter G M Wuts; Lloyd J Simons; Brian P Metzger; Rachel C Sterling; Jerry L Slightom; Ake P Elhammer
Journal:  ACS Med Chem Lett       Date:  2015-04-23       Impact factor: 4.345

8.  Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.

Authors:  Nuo Sun; Dongmei Li; William Fonzi; Xin Li; Lixin Zhang; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 9.  Plant antimicrobial agents and their effects on plant and human pathogens.

Authors:  Rocío González-Lamothe; Gabriel Mitchell; Mariza Gattuso; Moussa S Diarra; François Malouin; Kamal Bouarab
Journal:  Int J Mol Sci       Date:  2009-07-31       Impact factor: 6.208

Review 10.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.